Our Approach
The Problem with Current Models
Most new drugs are first tested in animals before reaching human trials. While animal studies can give early clues, the truth is simple: animals are not humans. Their biology, metabolism, and physiology are fundamentally different. This is why treatments that look promising in mice or rats often fail in people. In fact, the majority of drugs that enter clinical trials never make it to patients-costing time, money, and hope. Traditional flat cell cultures are also too simple, missing the complexity of real tissues.
Our Approach
At DynamicBio Technologies, we build models that better mimic human biology from the start.
- Engineered Substrates give cells a more natural surface to grow on, so they behave more like they do in the human body.
- Dynamic Culture Systems expose cells to forces and environments that replicate how tissues actually experience stress, flow, and movement.
- 3D Biofabrication allows us to create tissue-like structures that bring multiple cell types together in realistic ways.
By combining biology and engineering, our models recreate human conditions with far greater accuracy than animal testing or simple plastic dishes.
Why It Matters
Our approach has one clear goal: make drug testing more human-relevant. With better models, researchers can:
- Predict which drugs will work in people - earlier and more reliably.
- Reduce dependence on animal testing.
- Understand disease processes with more precision.
- Accelerate discovery while lowering risk and cost.
This means therapies can reach patients faster, with greater safety and effectiveness.
